PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,703,000 | +5.7% | 4,350,358 | -2.4% | 0.00% | 0.0% |
| Q2 2020 | $12,970,000 | +4.0% | 4,457,366 | +0.7% | 0.00% | -25.0% |
| Q1 2020 | $12,477,000 | -13.0% | 4,424,451 | +0.2% | 0.00% | +33.3% |
| Q4 2019 | $14,334,000 | +48.1% | 4,417,472 | -1.4% | 0.00% | +50.0% |
| Q3 2019 | $9,677,000 | -33.5% | 4,480,573 | -3.3% | 0.00% | -33.3% |
| Q2 2019 | $14,554,000 | -16.6% | 4,635,205 | -1.1% | 0.00% | -25.0% |
| Q1 2019 | $17,443,000 | +28.1% | 4,688,954 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $13,616,000 | +9.9% | 4,695,518 | -0.3% | 0.00% | +33.3% |
| Q3 2018 | $12,389,000 | +7.1% | 4,710,930 | -4.7% | 0.00% | 0.0% |
| Q2 2018 | $11,566,000 | -20.9% | 4,942,944 | -0.6% | 0.00% | -25.0% |
| Q1 2018 | $14,623,000 | +57.2% | 4,973,948 | +46.5% | 0.00% | +100.0% |
| Q4 2017 | $9,303,000 | -17.5% | 3,395,187 | +2.1% | 0.00% | -33.3% |
| Q3 2017 | $11,274,000 | +60.4% | 3,325,770 | +16.8% | 0.00% | +50.0% |
| Q2 2017 | $7,030,000 | +61.8% | 2,846,346 | +48.7% | 0.00% | +100.0% |
| Q1 2017 | $4,346,000 | -32.6% | 1,914,616 | -37.1% | 0.00% | -50.0% |
| Q4 2016 | $6,450,000 | -35.0% | 3,042,559 | +2.8% | 0.00% | -33.3% |
| Q3 2016 | $9,919,000 | +9.9% | 2,961,025 | +3.0% | 0.00% | 0.0% |
| Q2 2016 | $9,029,000 | -4.2% | 2,875,245 | +1.6% | 0.00% | 0.0% |
| Q1 2016 | $9,421,000 | +54.6% | 2,828,867 | +64.4% | 0.00% | +50.0% |
| Q4 2015 | $6,093,000 | -28.0% | 1,721,203 | +2.3% | 0.00% | -33.3% |
| Q3 2015 | $8,462,000 | -50.2% | 1,682,407 | -36.3% | 0.00% | -40.0% |
| Q2 2015 | $16,980,000 | -10.1% | 2,640,500 | -1.6% | 0.01% | -16.7% |
| Q1 2015 | $18,879,000 | -7.1% | 2,683,579 | +1.8% | 0.01% | 0.0% |
| Q4 2014 | $20,326,000 | +1.3% | 2,636,361 | -1.9% | 0.01% | 0.0% |
| Q3 2014 | $20,065,000 | -22.5% | 2,686,057 | +0.5% | 0.01% | -25.0% |
| Q2 2014 | $25,875,000 | +18.0% | 2,672,945 | +1.3% | 0.01% | +14.3% |
| Q1 2014 | $21,930,000 | -17.1% | 2,638,947 | -15.8% | 0.01% | -12.5% |
| Q4 2013 | $26,446,000 | +23.9% | 3,133,465 | +17.0% | 0.01% | 0.0% |
| Q3 2013 | $21,350,000 | -5.6% | 2,678,896 | -8.6% | 0.01% | 0.0% |
| Q2 2013 | $22,626,000 | – | 2,930,852 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |